Extract

The purpose of this study is to evaluate the biological effects of abemaciclib in combination with anastrozole and compare those to the effects of abemaciclib alone and anastrozole alone in the tumors of postmenopausal women with hormone receptor positive (HR+), human epidermal growth factor receptor 2 (HER2) negative breast cancer.

Inclusion criteria

• Breast Cancer ,Hormone Receptor Positive Tumor ,Early-Stage Breast Carcinoma

Country

• Austria
• Belgium
• Canada
• Germany
• Italy
• Korea, Republic of
• Netherlands
• Spain
• Taiwan, Province of China
• United States

Links

• nct
• ictrp